Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma

Radiotherapy and Oncology

Volumn 85, Issue 1, 2007, Pages 17-23

  Daoud, Jamel ^a   Toumi, Nabil ^a   Siala, Wissem ^a   Ghorbel, Abdelmonem ^b   Drira, Mohamed Mokthar ^b   Frikha, Mounir ^a  

^a Department of Radiotherapy ^*

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Bifractionated; Conventional; Nasopharyngeal carcinoma; Prognostic; Radiotherapy; Survival

Indexed keywords

CISPLATIN; EPIRUBICIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DYSPHAGIA; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKIN EXFOLIATION; SKIN FIBROSIS; SKIN TOXICITY; STATISTICAL ANALYSIS; SURVIVAL; ADOLESCENT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; MIDDLE AGED; MORTALITY; NASOPHARYNX TUMOR; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 35248884898     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.01.013     Document Type: Article

References (36)

1. Al-sarraf M., Leblanc M., Shanker Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomised intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
2. Ang K.K. Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 8 (1998) 230-236
3. Bentzen S.M., and Dische S. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner. Radiother Oncol 51 (1999) 105-107
4. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
5. Budach W., Hehr T., Budach V., et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6 (2006) 28
6. Cheng J.S. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future trials. Int J radiat Oncol Biol Phys 50 (2001) 717-726
7. Chua D.T., Sham J.S., Choy D., et al. Preliminary report of the Asian-Occeanian clinical oncology association randomised trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Occeanian clinical oncology association nasopharynx study group. Cancer 83 (1998) 2270-2283
8. Cooper J.S. Editorial. Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx. Int J radiat Oncol Biol Phys 48 (2000) 1277-1279
9. Cummings B.J., Keane T.J., Pintilie M., et al. A prospective randomised trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinoma of pharynx (Abstract). Int J radiat Oncol Biol Phys 35 (1996) 235
10. Franchin G., Vaccher E., Talamini R., et al. Nasopharyngeal cancer WHO type II-III: mono-institutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy. Oral oncol 38 (2002) 137-144
11. Frikha M., Bouaziz M., Daoud J., et al. Evaluation de la réponse tumorale et ganglionnaire à la chimiothérapie première dans les carcinomes indifferenciés du nasopharynx. Bull. cancer 84 (1997) 401-407
12. Fu K.K., Pajak T.F., Trotti A., et al. A radiation therapy oncology group (RTOG) phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
13. Galiana R., Boladeras A., Mesia R., et al. Twice a day radiotherapy for head end neck cancer: the Catalan institute of oncology experience. Radiother Oncol 64 (2002) 19-27
14. Garden A.S., Morrison W.H., Ang K.K., et al. Hyperfractionated radiation in the treatment of squamous cell carcinoma of the head and neck: a comparison of two fraction schedules. Int J radiat Oncol Biol Phys 31 (1995) 493-502
15. Hong S., Wu H., Chie E., et al. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma. Int J radiat Oncol Biol Phys 45 (1999) 901-905
16. Horiot J., Lefur R., N'Guyen T., et al. Hyperfraction versus conventional fraction in oropharyngeal carcinoma: final analysis of a randomised trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
17. Horiot J.C., Lefur R., Schraub S., et al. Status of the experience of the EORTC co-operative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes. Semin Radiat Oncol 2 (1992) 34-37
18. Huang S.C. Nasopharyngeal cancer. A review of 1605 patients treated radically with cobalt 60. Int J radiat Oncol Biol Phys 6 (1980) 401-407
19. Huang S.C., Lui L.T., and Lynn T.S. Nasopharyngeal cancer: study III A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 11 (1985) 1789-1793
20. International nasopharynx cancer study group. VUMCA I trial. Preliminary results of a randomised trial comparing neoadjuvant chemotherapy (Cisplatin, Epirubicin, Bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥N2 M0) undifferentiated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1996;35:463-9.
21. Jackson S.M., Weir L.M., Hay J.H., et al. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiat Oncol 43 (1997) 39-46
22. Jen Y.M., Lin Y.S., Wan F.S., et al. Dose escalation using twice daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing results in a happier ending. Int J radiat Oncol Biol Phys 54 (2002) 14-22
23. Jian J.M., Cheng S.H., Tsai S.Y., et al. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy. Int J radiat Oncol Biol Phys 53 (2002) 344-352
24. Lee A.W.M., Poon Y.F., Foo W., et al. A retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985, overall survival and patterns of failure. Int J radiat Oncol Biol Phys 23 (1992) 261-270
25. Leung S.F., Kreel L., and Tsao S.Y. Asymptomatic temporal lobe injury after radiotherapy of nasopharyngeal carcinoma: incidence and determinants. Br J Radiol 65 (1992) 710-714
26. Lin L.C., and Jan J.S. Locally advanced nasopharyngeal cancer: long term outcomes of radiation therapy. Radiology 211 (1999) 513-518
27. Poulsen M.G., Denham J.W., Peters L.J., et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck. A trans Tasman radiation oncology group study. Radiother Oncol 60 (2001) 113-122
28. Pinto L., Canary P., Aranjo C., et al. Prospective randomised trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21 (1991) 557-562
29. Sallemi A, Hsairi M, Achour N, et al. Registre du cancer du sud tunisien. Edition 2002.
30. Santos J.A., Gonzalez C., Cuesta P., et al. Impact of changes in the treatment of nasopharyngeal carcinoma: an experience of 30 years. Radiother Oncol 36 (1995) 121-127
31. Teo P.M.L., Kwan W.H., Leung S.F., et al. Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma. Br J Radiol 69 (1996) 241-248
32. Teo P.M.L., Leung S.F., Chan A.T.C., et al. Final report of a randomised trial on altered fractinated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 (2000) 1311-1322
33. Teo P.M.L., Yu P., Lee W.Y., et al. Significant prognostic factor after primary radiotherapy in 903 non disseminated nasopharyngeal carcinoma evaluated by computed tomography. Int J Radiat Oncol Biol Phys 36 (1996) 291-304
34. Wang C.C. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results. Cancer 63 (1989) 2461-2467
35. Wang C.C. Accelerated fractionation: the do's and don'ts. Int J Radiat Oncol Biol Phys 32 (1995) 889-890
36. Wang C.C., Nakfoor B.M., Spiro I.J., et al. Role of accelerated fractionated irradiation for supraglottic carcinoma. Assessment of results. Cancer J Sci Am 3 (1997) 88-91